市場調査レポート
商品コード
1459081

オメガ3の世界市場:タイプ別、用途別、由来別、地域別 - 予測(~2029年)

Omega-3 Market by Type (DHA, EPA, and ALA), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formula, and Pet Food & Feed), Source (Marine and Plant), and Region - Global Forecast to 2029

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 299 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
オメガ3の世界市場:タイプ別、用途別、由来別、地域別 - 予測(~2029年)
出版日: 2024年02月20日
発行: MarketsandMarkets
ページ情報: 英文 299 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のオメガ3の市場規模は、2024年に75億米ドルと推定され、2029年までに141億米ドルに達し、予測期間にCAGRで13.4%の成長が見込まれます。

オメガ3脂肪酸の新たな健康上の利点や用途を明らかにすることに焦点を当てた継続的な研究開発の試みは、技術革新を促進し、オメガ3製品の市場の将来性を拡大しています。さらに、マイクロカプセル化やナノエマルジョンなどのオメガ3製品の製剤やデリバリー方法の継続的な進歩は、オメガ3サプリメントのバイオアベイラビリティ、味、安定性を向上させ、より幅広い消費者層を引き付けています。さらに、世界中での高齢化の進行に伴い、健康的な加齢と予防医療への関心が高まっており、認知機能や関節の健康維持に役立つとされるオメガ3系サプリメントへの需要が高まっています。これらの要因が総合的に、オメガ3市場の継続的な成長に寄与しています。

調査範囲
調査対象年 2024年~2029年
基準年 2023年
予測期間 2024年~2029年
単位 米ドル
セグメント タイプ別、由来別、用途別、地域別
対象地域 北米、欧州、南米、アジア太平洋、その他の地域

「予防医療と革新的生産技術への注目の高まりがオメガ3市場の需要を促進します。」

医療システムが慢性疾患の負担に対処するための予防策をますます重視するようになるにつれて、オメガ3サプリメントの重要性に対する認識が高まっています。これらのサプリメントは、心臓の健康、認知機能、関節の健康をサポートする可能性があるとして注目を集めています。診断と個別化医療の進歩に伴い、健康リスクの早期発見がより現実的になりつつあり、オメガ3サプリメントを含む的を絞った介入が可能になっています。このような予防医療戦略と個別化介入の融合は、人々が健康とウェルビーイングを管理するための積極的なアプローチを求めるにつれて、オメガ3市場の成長を促進すると予測されます。

革新的な生産技術は、製造プロセスを合理化し、効率を高め、生産性を高めることによって、オメガ3市場で重要な役割を果たしています。これにより、オメガ3メーカーは資源の利用を最適化し、生産コストを下げながら、消費者の需要の増加に効果的に対応することができます。さらに、これらの先進の方法は、一貫した品質と純度を保証し、厳格な規制基準と消費者の期待に応えます。その結果、消費者はオメガ3製品への信頼を高め、リピート購入とブランドロイヤルティにつながります。全体として、こうした技術の進歩は、効率性、品質、製品の多様性、バイオアベイラビリティ、持続可能性を向上させることにより、市場成長を促進します。進化する消費者の需要に適応し、健康とウェルネスの部門における新たな機会を活用することで、メーカーは市場でのプレゼンスを拡大し、より幅広い消費者層のニーズに応えることができます。

「2023年、EPAはオメガ3市場のタイプ別で2番目に大きいセグメントです。」

オメガ3市場は、EPA(エイコサペンタエン酸)の需要の増加を示しています。EPAはオメガ3市場で第2位のシェアを占めており、そのプレゼンスの高まりは、消費者の選好に合わせた健康ソリューションを提供することの重要性を明示しています。特定の健康効果を提供する製品に対する消費者の志向が高まる中、EPAを豊富に含むオメガ3サプリメントは、全体的な健康を増進し、多様な健康ニーズに対応する可能性があるとして、勢いを増しています。

当レポートでは、世界のオメガ3市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • オメガ3市場の企業にとって魅力的な機会
  • アジア太平洋のオメガ3市場:タイプ別、主要国別
  • オメガ3市場:用途別
  • オメガ3市場:タイプ別
  • オメガ3市場:由来別

第5章 市場の概要

  • イントロダクション
  • マクロ経済指標
    • 予防医療支出
    • 老年人口の増加
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 投資と資金調達のシナリオ

第6章 産業の動向

  • イントロダクション
  • バリューチェーン分析
    • 研究・製品開発
    • 製造
    • マーケティング・販売
    • 流通
    • アフターサービス
  • 技術分析
    • 分子蒸留
    • 藻類発酵
  • 特許分析
  • エコシステム分析
    • デマンドサイド
    • サプライサイド
  • 貿易分析
    • 輸出データ
    • 輸入データ
  • 価格分析
    • 主要企業が提供する製品の平均販売価格の動向:由来別
    • オメガ3の平均販売価格の動向:由来別
    • 海洋由来の平均販売価格の動向:地域別
    • 植物由来の平均販売価格の動向:地域別
  • 顧客のビジネスに影響を与える動向/混乱
  • 主な会議とイベント(2024年)
  • 規制情勢
    • 規制機関、政府機関、その他の組織
    • 規制情勢
  • ケーススタディ分析
  • ポーターのファイブフォース分析
  • 主なステークホルダーと購入基準

第7章 オメガ3市場:タイプ別

  • イントロダクション
  • ドコサヘキサエン酸
  • エイコサペンタエン酸
  • α-リノレン酸

第8章 オメガ3市場:由来別

  • イントロダクション
  • 海洋
  • 植物

第9章 オメガ3市場:用途別

  • イントロダクション
  • 栄養補助食品
  • 機能性食品・飲料
  • 製薬
  • 乳児用調製粉乳
  • ペットフード、飼料

第10章 オメガ3市場:地域別

  • イントロダクション
  • 北米
    • 北米の景気後退の影響
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の景気後退の影響
    • ドイツ
    • 英国
    • フランス
    • ノルウェー
    • イタリア
    • スペイン
    • オランダ
    • その他の欧州
  • アジア太平洋
    • アジア太平洋の景気後退の影響
    • 中国
    • インド
    • 日本
    • オーストラリア
    • ニュージーランド
    • その他のアジア太平洋
  • 南米
    • 南米の景気後退の影響
    • ブラジル
    • アルゼンチン
    • その他の南米
  • その他の地域
    • その他の地域の景気後退の影響
    • アフリカ
    • 中東

第11章 競合情勢

  • 概要
  • 市場シェア分析(2022年)
  • 主要企業の戦略/有力企業(2020年~2024年)
  • ブランド/製品の分析
  • 収益分析:セグメント別(2020年~2022年)
  • 主要企業の年間収益(2022年)と収益成長率(2020年~2022年)
  • EBIT/EBITDA分析(2022年)
  • 世界の主な市場参入企業のスナップショット(2022年)
  • 企業評価と財務指標
  • 企業の評価マトリクス:主要企業(2022年)
  • 企業の評価マトリクス:スタートアップ/中小企業(2022年)
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • BASF SE
    • CARGILL, INCORPORATED
    • DSM-FIRMENICH
    • ADM
    • KERRY GROUP PLC
    • CRODA INTERNATIONAL PLC
    • ORKLA
    • CORBION
    • PELAGIA AS
    • KD PHARMA GROUP SA
    • GC RIEBER
    • COOKE AQUACULTURE INC.
    • ALGISYS BIOSCIENCES, INC.
    • GOLDEN OMEGA
    • POLARIS
  • その他の企業
    • BTSA
    • FARBEST BRANDS
    • KINOMEGA BIOPHARM INC.
    • PHARMA MARINE AS
    • RIMFROST AS
    • ALGARITHM
    • SOLUTEX
    • CELLANA INC.
    • SINOMEGA BIOTECH ENGINEERING CO., LTD
    • ALGAECYTES

第13章 隣接市場と関連市場

  • イントロダクション
  • 制限事項
  • コラーゲン市場
    • 市場の定義
    • 市場の概要
  • 藻類製品市場
    • 市場の定義
    • 市場の概要

第14章 付録

目次
Product Code: FB 2759

The global market for omega-3 is estimated at USD 7.5 billion in 2024 and is projected to reach USD 14.1 billion by 2029, at a CAGR of 13.4% during the forecast period. Ongoing research and development endeavors focused on uncovering new health benefits and applications of Omega-3 fatty acids are driving innovation and expanding the market potential for Omega-3 products. Additionally, continuous advancements in Omega-3 product formulations and delivery methods, such as microencapsulation and nanoemulsions, are improving the bioavailability, taste, and stability of Omega-3 supplements, thus attracting a wider consumer base. Furthermore, with a growing aging population worldwide, there is a heightened emphasis on healthy aging and preventive healthcare, which is fueling demand for Omega-3 supplements recognized for their potential advantages in maintaining cognitive function and joint health. Collectively, these factors contribute to the ongoing growth of the Omega-3 market.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Type, Source, Application, and Region
Regions coveredNorth America, Europe, South America, Asia Pacific, and RoW

"Increase in focus on preventive healthcare and innovative production technologies fuel demand for omega-3 market."

As healthcare systems increasingly emphasize preventive measures to tackle the burden of chronic diseases, there's a rising recognition of the importance of Omega-3 supplements. These supplements have garnered attention for their potential to support heart health, cognitive function, and joint health. With ongoing advancements in diagnostics and personalized medicine, early detection of health risks is becoming more feasible, allowing for targeted interventions that include Omega-3 supplementation. This convergence of preventive healthcare strategies and personalized interventions is expected to fuel the growth of the Omega-3 market as individuals seek proactive approaches to manage their health and well-being.

Innovative production technologies play a vital role in the Omega-3 market by streamlining manufacturing processes, enhancing efficiency, and boosting productivity. This enables Omega-3 manufacturers to effectively address increasing consumer demand while optimizing resource utilization and lowering production costs. Moreover, these advanced methods ensure consistent quality and purity, meeting rigorous regulatory standards and consumer expectations. As a result, consumers develop trust in the reliability of Omega-3 products, leading to repeat purchases and brand loyalty. Overall, these technological advancements drive market growth by improving efficiency, quality, diversity of products, bioavailability, and sustainability. By adapting to evolving consumer demands and leveraging emerging opportunities in the health and wellness sector, manufacturers can expand their market presence and meet the needs of a broader consumer base.

"In 2023, EPA stood as the second-largest segment within the by type of omega-3 market. "

The Omega-3 market is witnessing an increasing demand for EPA (Eicosapentaenoic Acid) owing to its well-established health advantages, notably in cardiovascular health and inflammation management. As the EPA segment claims the second-largest portion of the Omega-3 market, its rising prominence emphasizes its significance in fulfilling consumer preferences for tailored health solutions. With a growing consumer inclination towards products offering specific health benefits, EPA-rich Omega-3 supplements are gaining momentum for their potential to enhance overall well-being and address diverse health needs.

"Within the source segment, plant source is expected to grow during the forecast period constantly."

The depletion of fish stocks and the environmental repercussions of fish oil extraction are prompting consumers to seek more sustainable alternatives. Plant-based sources like algae, chia seeds, and flaxseeds offer environmentally friendly options for obtaining Omega-3 fatty acids. A growing number of individuals are embracing vegan or vegetarian lifestyles, and plant-derived Omega-3s align with their dietary preferences and ethical considerations regarding animal products. Manufacturers are continuously innovating within this sector, creating more potent and easily absorbable plant-based Omega-3 products. Examples include oils derived from microalgae and chia seed extracts encapsulated for enhanced efficacy. Investors are acknowledging the potential of this market segment, leading to heightened research and development efforts, which in turn propel further growth.

"The omega-3 market in Europe is anticipated to maintain consistent growth throughout the forecast period."

Europe's aging population, prone to age-related health issues such as cardiovascular disease and cognitive decline, is increasingly turning to Omega-3 fatty acids for potential health benefits. Regulatory bodies like the European Food Safety Authority (EFSA) have validated health claims associated with Omega-3 fatty acids, bolstering consumer confidence and facilitating marketing efforts for Omega-3 enriched products. For instance, according to the European Union (2020), the median age in the EU-27 is projected to rise by 4.5 years between 2019 and 2050, reaching 48.2 years.

The Break-up of Primaries:

By Company Type: Tier 1 - 30%, Tier 2 - 45%, Tier 3 - 25%

By Designation: CXOs - 25%, Managers - 50%, Executives - 25%

By Region: North America - 25%, Europe - 25%, APAC - 30%, South America - 10%, and RoW - 10%

Key players in this market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), Croda International Plc (UK), Orkla (Norway), Corbion (Netherlands), Pelagia AS (US), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), Polaris (France), Nordic Naturals (US), and Now Foods (US).

Research Coverage:

The report segments the omega-3 market based on type, source, application, and region. In terms of insights, this report has focused on various levels of analyses-the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the omega-3 market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services, key strategies, contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the omega-3 market. Competitive analysis of upcoming startups in the omega-3 market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall omega-3 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers:

  • Analysis of key drivers (Increase in application profiling and existing applications finding new markets, innovative production technologies, and consumer awareness regarding the health benefits of omega-3), restraints (lower fish oil supply due to sustainability issues among fisheries, and lack of clarity among consumers about daily recommended intake) opportunities (microencapsulation, awareness about certified food ingredients, research for development of alternative sources to obtain omega-3), and challenges (high cost involved in R&D activities, and highly unstable fish oil prices).
  • Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the omega-3 market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the omega-3 market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the omega-3 market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), Croda International Plc (UK), Orkla (Norway), Corbion (Netherlands), Pelagia AS (US), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), Polaris (France), Nordic Naturals (US), Now Foods (US), BTSA (Spain), Farbest Brands (US), KinOmega Biopharm Inc (China), Pharma Marine AS (Norway), Rimfrost AS (Norway), Algarithm (Canada), Solutex (Spain), Cellana Inc (US), Nature's Way Brands (US), and AlgaeCytes UK) among others in the omega-3 market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 REGIONAL SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 UNITS CONSIDERED
    • 1.5.1 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2023
    • 1.5.2 VOLUME UNIT
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
      • 2.1.2.2 List of key participants in primary interviews
      • 2.1.2.3 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 2 OMEGA-3 MARKET: DEMAND-SIDE CALCULATION
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach to estimate market size using top-down analysis
    • FIGURE 3 OMEGA-3 MARKET: SUPPLY-SIDE CALCULATION
    • FIGURE 4 OMEGA-3 MARKET: SUPPLY SIDE
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS AND RISK ASSESSMENT
  • 2.6 RECESSION IMPACT ANALYSIS
    • 2.6.1 RECESSION MACROINDICATORS
    • FIGURE 6 INDICATORS OF RECESSION
    • FIGURE 7 GLOBAL INFLATION RATE, 2011-2022
    • FIGURE 8 GLOBAL GDP, 2011-2022 (USD TRILLION)
    • FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON OMEGA-3 MARKET
    • FIGURE 10 OMEGA-3 MARKET: EARLIER FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

    • TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2024 VS. 2029
    • FIGURE 11 OMEGA-3 MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 OMEGA-3 MARKET: REGIONAL SHARE, 2023

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
    • FIGURE 15 RISING CHRONIC DISEASES TO DRIVE MARKET GROWTH
  • 4.2 OMEGA-3 MARKET IN ASIA PACIFIC, BY TYPE AND KEY COUNTRIES
    • FIGURE 16 DOCOSAHEXAENOIC ACID SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES OF ASIA PACIFIC MARKET IN 2023
  • 4.3 OMEGA-3 MARKET, BY APPLICATION
    • FIGURE 17 DIETARY SUPPLEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 OMEGA-3 MARKET, BY TYPE
    • FIGURE 18 DOCOSAHEXAENOIC ACID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE FROM 2024 TO 2029
  • 4.5 OMEGA-3 MARKET, BY SOURCE
    • FIGURE 19 MARINE SEGMENT TO CLAIM LARGER MARKET SHARE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE
    • FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2020
    • 5.2.2 GROWING GERIATRIC POPULATION
    • FIGURE 21 POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2012-2022
  • 5.3 MARKET DYNAMICS
    • FIGURE 22 MARKET DYNAMICS: OMEGA-3 MARKET
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growing consumer awareness regarding health benefits of omega-3
    • TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
      • 5.3.1.2 Increasing use of omega-3 fatty acids in food and feed products
        • 5.3.1.2.1 Rising demand for mother & infant nutrition products
    • TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM)
        • 5.3.1.2.2 Growth focus of food processing companies on fortification
        • 5.3.1.2.3 Increasing applications in pet food and feed
    • FIGURE 23 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
      • 5.3.1.3 Growing adoption of innovative production technologies
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Lower fish oil supply due to sustainability issues among fisheries
      • 5.3.2.2 Lack of clarity among consumers about daily recommended intake and health claims
    • TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Increasing research for development of alternative sources to obtain omega-3
    • TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
        • 5.3.3.1.1 Rising consumer demand for plant-based products
          • 5.3.3.1.1.1 Growing focus on microalgae-based omega-3 production
    • FIGURE 24 MICROALGAE PROCESSING FOR OMEGA-3
          • 5.3.3.1.1.2 Side-effects and allergies related to fish-based products
      • 5.3.3.2 Favorable regulatory environment
      • 5.3.3.3 Application of microencapsulation technology to regulate release of nutrients in fortified food & beverages
    • 5.3.4 CHALLENGES
      • 5.3.4.1 High costs involved in R&D activities
      • 5.3.4.2 Highly unstable fish oil prices
      • 5.3.4.3 Instability of omega-3 oils
  • 5.4 INVESTMENT AND FUNDING SCENARIO
    • FIGURE 25 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 VALUE CHAIN ANALYSIS
    • 6.2.1 RESEARCH & PRODUCT DEVELOPMENT
    • 6.2.2 MANUFACTURING
    • 6.2.3 MARKETING & SALES
    • 6.2.4 DISTRIBUTION
    • 6.2.5 POST-SALES SERVICES
    • FIGURE 26 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
  • 6.3 TECHNOLOGY ANALYSIS
    • 6.3.1 MOLECULAR DISTILLATION
    • 6.3.2 ALGAE FERMENTATION
  • 6.4 PATENT ANALYSIS
    • FIGURE 27 KEY PATENTS GRANTED IN OMEGA-3 MARKET, 2014-2024
    • FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET, 2014-2024
    • 6.4.1 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET (2014-2023)
  • 6.5 ECOSYSTEM ANALYSIS
    • 6.5.1 DEMAND SIDE
    • 6.5.2 SUPPLY SIDE
    • TABLE 7 ROLE OF PARTICIPANTS IN ECOSYSTEM
    • FIGURE 29 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS
  • 6.6 TRADE ANALYSIS
    • 6.6.1 EXPORT DATA
    • TABLE 8 EXPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
    • 6.6.2 IMPORT DATA
    • TABLE 9 IMPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
  • 6.7 PRICING ANALYSIS
    • 6.7.1 AVERAGE SELLING PRICE TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE
    • TABLE 10 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE, 2023 (USD/KG)
    • 6.7.2 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY SOURCE
    • TABLE 11 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF OMEGA-3, BY SOURCE, 2019-2023 (USD/KG)
    • 6.7.3 AVERAGE SELLING PRICE TREND OF MARINE SOURCES, BY REGION
    • TABLE 12 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF MARINE SOURCES, BY REGION, 2019-2023 (USD/KG)
    • 6.7.4 AVERAGE SELLING PRICE TREND OF PLANT SOURCES, BY REGION
    • TABLE 13 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PLANT SOURCES, BY REGION, 2019-2023 (USD/KG)
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 30 TRENDS INFLUENCING OMEGA-3 MARKET
  • 6.9 KEY CONFERENCES AND EVENTS, 2024
    • TABLE 14 OMEGA-3 MARKET: LIST OF CONFERENCES AND EVENTS, 2023-2024
  • 6.10 REGULATORY LANDSCAPE
    • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.10.2 REGULATORY LANDSCAPE
      • 6.10.2.1 North America
        • 6.10.2.1.1 US
        • 6.10.2.1.2 Canada
      • 6.10.2.2 Europe
      • 6.10.2.3 Asia Pacific
        • 6.10.2.3.1 China
        • 6.10.2.3.2 Japan
        • 6.10.2.3.3 India
      • 6.10.2.4 South America
        • 6.10.2.4.1 Brazil
        • 6.10.2.4.2 Argentina
        • 6.10.2.4.3 Chile
      • 6.10.2.5 RoW
        • 6.10.2.5.1 South Africa
        • 6.10.2.5.2 UAE
  • 6.11 CASE STUDY ANALYSIS
    • 6.11.1 VERAMARIS ASSISTED BLAIR IN PRODUCING OMEGA-3 FATTY ACIDS FROM NATURAL MARINE ALGAE
    • 6.11.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
    • 6.11.3 OMEGA-3 SUPPLEMENTS HELPED REDUCE SEIZURE FREQUENCY IN GREAT DANE SUFFERING FROM REFRACTORY CANINE EPILEPSY
  • 6.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 18 PORTER'S FIVE FORCES ANALYSIS
    • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.12.2 BARGAINING POWER OF SUPPLIERS
    • 6.12.3 BARGAINING POWER OF BUYERS
    • 6.12.4 THREAT OF SUBSTITUTES
    • 6.12.5 THREAT OF NEW ENTRANTS
  • 6.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE
    • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE (%)
    • 6.13.2 BUYING CRITERIA
    • FIGURE 32 BUYING CRITERIA
    • TABLE 20 KEY BUYING CRITERIA FOR SOURCE SEGMENT

7 OMEGA-3 MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • FIGURE 33 DOCOSAHEXAENOIC ACID SEGMENT TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 21 OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 22 OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 7.2 DOCOSAHEXAENOIC ACID
    • 7.2.1 LOWERED RISK OF ALZHEIMER'S DISEASE TO DRIVE MARKET GROWTH
    • TABLE 23 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
    • TABLE 24 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 25 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 7.3 EICOSAPENTAENOIC ACID
    • 7.3.1 REDUCED SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
    • TABLE 26 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
    • TABLE 27 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 28 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 7.4 ALPHA-LINOLENIC ACID
    • 7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
    • TABLE 29 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
    • TABLE 30 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 31 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)

8 OMEGA-3 MARKET, BY SOURCE

  • 8.1 INTRODUCTION
    • FIGURE 34 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
    • TABLE 32 OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 33 OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 34 OMEGA-3 MARKET, BY SOURCE, 2019-2023 (KT)
    • TABLE 35 OMEGA-3 MARKET, BY SOURCE, 2024-2029 (KT)
  • 8.2 MARINE
    • 8.2.1 SURGING DEMAND AMONG PREGNANT WOMEN FOR HEALTHY FETAL DEVELOPMENT TO DRIVE MARKET
    • TABLE 36 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
    • TABLE 37 MARINE: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 38 MARINE: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 39 MARINE: OMEGA-3 MARKET, BY REGION, 2019-2023 (KT)
    • TABLE 40 MARINE: OMEGA-3 MARKET, BY REGION, 2024-2029 (KT)
    • TABLE 41 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2019-2023 (USD MILLION)
    • TABLE 42 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2024-2029 (USD MILLION)
  • 8.3 PLANT
    • 8.3.1 GROWING USE OF FLAX SEEDS TO PREVENT CANCER TO BOOST DEMAND
    • TABLE 43 PLANT: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 44 PLANT: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 45 PLANT: OMEGA-3 MARKET, BY REGION, 2019-2023 (KT)
    • TABLE 46 PLANT: OMEGA-3 MARKET, BY REGION, 2024-2029 (KT)
    • TABLE 47 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2019-2023 (USD MILLION)
    • TABLE 48 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2024-2029 (USD MILLION)

9 OMEGA-3 MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • FIGURE 35 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • TABLE 49 OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 50 OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 9.2 DIETARY SUPPLEMENT
    • 9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIET TO DRIVE MARKET
    • TABLE 51 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 52 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.3 FUNCTIONAL FOOD & BEVERAGE
    • 9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
    • TABLE 53 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 54 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.4 PHARMACEUTICAL
    • 9.4.1 GROWING APPLICATION TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
    • TABLE 55 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 56 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.5 INFANT FORMULA
    • 9.5.1 RISING CONSUMPTION OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
    • TABLE 57 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 58 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.6 PET FOOD AND FEED
    • 9.6.1 GREATER EMPHASIS ON BUILDING STRONG IMMUNITY IN PETS TO DRIVE MARKET
    • TABLE 59 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 60 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)

10 OMEGA-3 MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 36 INDIA TO RECORD FASTEST GROWTH IN GLOBAL OMEGA-3 MARKET
    • TABLE 61 OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 62 OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 63 OMEGA-3 MARKET, BY REGION, 2019-2023 (KT)
    • TABLE 64 OMEGA-3 MARKET, BY REGION, 2024-2029 (KT)
  • 10.2 NORTH AMERICA
    • FIGURE 37 NORTH AMERICA: REGIONAL SNAPSHOT
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 38 OMEGA-3 MARKET IN NORTH AMERICA: RECESSION IMPACT ANALYSIS
    • TABLE 65 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 66 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 67 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 68 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 69 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 70 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 71 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 72 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 73 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (KT)
    • TABLE 74 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (KT)
    • 10.2.2 US
      • 10.2.2.1 Growing demand for plant-based omega-3 dietary supplements to drive market
    • TABLE 75 US: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 76 US: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 77 US: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 78 US: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 79 US: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 80 US: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 81 US: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Increased application in functional food & beverages to boost demand
    • TABLE 82 CANADA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 83 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 84 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 85 CANADA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 86 CANADA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 87 CANADA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 88 CANADA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.2.4 MEXICO
      • 10.2.4.1 Growing focus on preventing heart diseases to drive market
    • TABLE 89 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 90 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 91 MEXICO: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 92 MEXICO: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 93 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 94 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 EUROPE: RECESSION IMPACT
    • FIGURE 39 OMEGA-3 MARKET IN EUROPE: RECESSION IMPACT ANALYSIS
    • TABLE 95 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 96 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 97 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 98 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 99 EUROPE: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 100 EUROPE: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 101 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 102 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 103 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (KT)
    • TABLE 104 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (KT)
    • 10.3.2 GERMANY
      • 10.3.2.1 Less fish consumption to boost demand for omega-3-based supplements
    • TABLE 105 GERMANY: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 106 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 107 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 108 GERMANY: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 109 GERMANY: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 110 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 111 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Ability to boost brain function and reduce inflammation to drive market
    • TABLE 112 UK: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 113 UK: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 114 UK: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 115 UK: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 116 UK: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 117 UK: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 118 UK: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 Ongoing innovations to boost quality and stability of omega-3-rich oils formulation to drive market
    • TABLE 119 FRANCE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 120 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 121 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 122 FRANCE: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 123 FRANCE: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 124 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 125 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.5 NORWAY
      • 10.3.5.1 Production of genetically modified canola to offer lucrative growth opportunities to players
    • TABLE 126 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 127 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 128 NORWAY: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 129 NORWAY: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 130 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 131 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.6 ITALY
      • 10.3.6.1 High production of dietary supplements, functional food products, and beverages to boost demand
    • TABLE 132 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 133 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 134 ITALY: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 135 ITALY: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 136 ITALY: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 137 ITALY: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.7 SPAIN
      • 10.3.7.1 Need for sufficient consumption of ALA, DHA and EPA from foods to accelerate demand
    • TABLE 138 SPAIN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 139 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 140 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 141 SPAIN: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 142 SPAIN: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 143 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 144 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.8 NETHERLANDS
      • 10.3.8.1 Growing incidences of depression, autism, and ADHD to drive market
    • TABLE 145 NETHERLANDS: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 146 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 147 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 148 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 149 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 150 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.3.9 REST OF EUROPE
    • TABLE 152 REST OF EUROPE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 153 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 154 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 40 ASIA PACIFIC: REGIONAL SNAPSHOT
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 41 OMEGA-3 MARKET IN ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    • TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (KT)
    • TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (KT)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing focus on product innovations and diversifications to drive market
    • TABLE 169 CHINA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 170 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 171 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 172 CHINA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 174 CHINA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing incidences of heart failure to drive market
    • TABLE 176 INDIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 177 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 178 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 179 INDIA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 180 INDIA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 181 INDIA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 182 INDIA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.4.4 JAPAN
      • 10.4.4.1 Rising use of innovative formulation technology to create opportunities for manufacturers of omega-3 products
    • TABLE 183 JAPAN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 184 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 185 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 186 JAPAN: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 188 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
    • TABLE 190 AUSTRALIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 191 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 192 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 193 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 194 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 195 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 196 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.4.6 NEW ZEALAND
      • 10.4.6.1 Increasing consumer awareness and government regulations for omega-3 supplements to drive market growth
    • TABLE 197 NEW ZEALAND: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 198 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 199 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 200 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 201 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 202 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 203 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 204 REST OF ASIA PACIFIC: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
    • TABLE 205 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 206 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 207 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 208 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 209 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 210 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • 10.5 SOUTH AMERICA
    • 10.5.1 SOUTH AMERICA: RECESSION IMPACT
    • FIGURE 42 OMEGA-3 MARKET IN SOUTH AMERIC: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 211 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 212 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 213 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 214 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 215 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 216 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 217 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 218 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 219 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (KT)
    • TABLE 220 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (KT)
    • 10.5.2 BRAZIL
      • 10.5.2.1 Rising demand for algal oils to drive market
    • TABLE 221 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 222 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 223 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 224 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 225 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 226 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.5.3 ARGENTINA
      • 10.5.3.1 Commercialization of omega-3 products to fuel market growth
    • TABLE 227 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 228 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 229 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 230 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 231 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 232 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.5.4 REST OF SOUTH AMERICA
    • TABLE 233 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 234 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 235 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 236 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 237 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 238 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • 10.6 ROW
    • 10.6.1 ROW: RECESSION IMPACT
    • FIGURE 43 OMEGA-3 MARKET IN ROW: RECESSION IMPACT ANALYSIS
    • TABLE 239 ROW: OMEGA-3 MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 240 ROW: OMEGA-3 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 241 ROW: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 242 ROW: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 243 ROW: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 244 ROW: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 245 ROW: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 246 ROW: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 247 ROW: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (KT)
    • TABLE 248 ROW: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (KT)
    • 10.6.2 AFRICA
    • TABLE 249 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 250 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 251 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 252 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 253 AFRICA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 254 AFRICA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 255 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 256 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.2.1 South Africa
        • 10.6.2.1.1 Prevalence of undernutrition among pregnant women and kids to drive demand
    • TABLE 257 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 258 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 259 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 260 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 261 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 262 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.2.2 Egypt
        • 10.6.2.2.1 Improved pediatric health conditions to boost demand
    • TABLE 263 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 264 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 265 EGYPT: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 266 EGYPT: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 267 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 268 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.2.3 Nigeria
        • 10.6.2.3.1 Rising prevalnce of artery diseases to boost demand
    • TABLE 269 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 270 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 271 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 272 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 273 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 274 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.2.4 Rest of Africa
    • TABLE 275 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 276 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 277 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 278 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 279 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 280 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • 10.6.3 MIDDLE EAST
    • TABLE 281 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 282 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 283 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 284 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 285 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 286 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 287 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 288 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.3.1 Saudi Arabia
        • 10.6.3.1.1 Ongoing innovations in omega-3 products to drive market
    • TABLE 289 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 290 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 291 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 292 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 293 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 294 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.3.2 UAE
        • 10.6.3.2.1 Increasing awareness among consumers about health products to drive market
    • TABLE 295 UAE: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 296 UAE: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 297 UAE: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 298 UAE: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 299 UAE: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 300 UAE: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.3.3 Qatar
        • 10.6.3.3.1 Growing research on algae to boost demand
    • TABLE 301 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 302 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 303 QATAR: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 304 QATAR: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 305 QATAR: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 306 QATAR: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
      • 10.6.3.4 Rest of Middle East
    • TABLE 307 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 308 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 309 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 310 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 311 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 312 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024-2029 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS, 2022
    • TABLE 313 OMEGA-3 MARKET: DEGREE OF COMPETITION
  • 11.3 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2020-2024
    • TABLE 314 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, 2020-2024
  • 11.4 BRAND/PRODUCT ANALYSIS
    • FIGURE 44 BRAND/PRODUCT ANALYSIS FOR KEY BRANDS
  • 11.5 SEGMENTAL REVENUE ANALYSIS, 2020-2022
    • FIGURE 45 THREE-YEAR SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN OMEGA-3 MARKET (USD BILLION)
  • 11.6 KEY PLAYERS' ANNUAL REVENUE, 2022 VS. REVENUE GROWTH, 2020-2022
    • FIGURE 46 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH (%), 2020-2022
  • 11.7 EBIT/EBITDA ANALYSIS, 2022
    • FIGURE 47 EBIT/EBITDA (USD BILLION)
  • 11.8 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
    • FIGURE 48 GLOBAL SNAPSHOT OF KEY PARTICIPANTS
  • 11.9 COMPANY VALUATION AND FINANCIAL METRICS
    • FIGURE 49 COMPANY VALUATION OF FEW MAJOR COMPANIES
    • FIGURE 50 EV/EBITDA OF KEY COMPANIES
  • 11.10 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2022
    • 11.10.1 STARS
    • 11.10.2 EMERGING LEADERS
    • 11.10.3 PERVASIVE PLAYERS
    • 11.10.4 PARTICIPANTS
    • FIGURE 51 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
    • 11.10.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.10.5.1 Company footprint
    • TABLE 315 OVERALL COMPANY FOOTPRINT
      • 11.10.5.2 Type footprint
    • TABLE 316 OMEGA-3 MARKET: BY TYPE FOOTPRINT
      • 11.10.5.3 Source footprint
    • TABLE 317 OMEGA-3 MARKET: BY SOURCE FOOTPRINT
      • 11.10.5.4 Application footprint
    • TABLE 318 OMEGA-3 MARKET: BY APPLICATION FOOTPRINT
      • 11.10.5.5 Region footprint
    • TABLE 319 OMEGA-3 MARKET: BY REGION FOOTPRINT
  • 11.11 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2022
    • 11.11.1 PROGRESSIVE COMPANIES
    • 11.11.2 RESPONSIVE COMPANIES
    • 11.11.3 DYNAMIC COMPANIES
    • 11.11.4 STARTING BLOCKS
    • FIGURE 52 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2022
    • 11.11.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
      • 11.11.5.1 List of key start-ups/SMEs
    • TABLE 320 OMEGA-3 MARKET: LIST OF KEY START-UPS/SMES
      • 11.11.5.2 Competitive benchmarking of key start-ups/SMEs
    • TABLE 321 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.12 COMPETITIVE SCENARIO
    • 11.12.1 PRODUCT LAUNCHES
    • TABLE 322 OMEGA-3 MARKET: PRODUCT LAUNCHES, JANUARY 2020- FEBRUARY 2024
    • 11.12.2 DEALS
    • TABLE 323 OMEGA-3 MARKET: DEALS, JANUARY 2020- FEBRUARY 2024
    • 11.12.3 EXPANSIONS
    • TABLE 324 OMEGA-3 MARKET: EXPANSIONS, JANUARY 2020- FEBRUARY 2024
    • 11.12.4 OTHERS
    • TABLE 325 OMEGA-3 MARKET: OTHERS, JANUARY 2020- FEBRUARY 2024

12 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 12.1 KEY PLAYERS
    • 12.1.1 BASF SE
    • TABLE 326 BASF SE: COMPANY OVERVIEW
    • FIGURE 53 BASF SE: COMPANY SNAPSHOT
    • TABLE 327 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 328 BASF SE: PRODUCT LAUNCHES
    • 12.1.2 CARGILL, INCORPORATED
    • TABLE 329 CARGILL, INCORPORATED: COMPANY OVERVIEW
    • FIGURE 54 CARGILL, INCORPORATED.: COMPANY SNAPSHOT
    • TABLE 330 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 331 CARGILL, INCORPORATED: DEALS
    • 12.1.3 DSM-FIRMENICH
    • TABLE 332 DSM-FIRMENICH: COMPANY OVERVIEW
    • FIGURE 55 DSM-FIRMENICH: COMPANY SNAPSHOT
    • TABLE 333 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 334 DSM-FIRMENICH: PRODUCT LAUNCHES
    • 12.1.4 ADM
    • TABLE 335 ADM: COMPANY OVERVIEW
    • FIGURE 56 ADM: COMPANY SNAPSHOT
    • TABLE 336 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.1.5 KERRY GROUP PLC
    • TABLE 337 KERRY GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
    • TABLE 338 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 339 KERRY GROUP PLC: DEALS
    • 12.1.6 CRODA INTERNATIONAL PLC
    • TABLE 340 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
    • FIGURE 58 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
    • TABLE 341 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.1.7 ORKLA
    • TABLE 342 ORKLA: COMPANY OVERVIEW
    • FIGURE 59 ORKLA: COMPANY SNAPSHOT
    • TABLE 343 ORKLA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 344 ORKLA: DEALS
    • 12.1.8 CORBION
    • TABLE 345 CORBION: COMPANY OVERVIEW
    • FIGURE 60 CORBION: COMPANY SNAPSHOT
    • TABLE 346 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 347 CORBION: PRODUCT LAUNCHES
    • TABLE 348 CORBION: EXPANSIONS
    • 12.1.9 PELAGIA AS
    • TABLE 349 PELAGIA AS: COMPANY OVERVIEW
    • FIGURE 61 PELAGIA AS: COMPANY SNAPSHOT
    • TABLE 350 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 351 PELAGIA AS: DEALS
    • 12.1.10 KD PHARMA GROUP SA
    • TABLE 352 KD PHARMA GROUP SA: COMPANY OVERVIEW
    • TABLE 353 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 354 KD PHARMA GROUP SA: EXPANSIONS
    • 12.1.11 GC RIEBER
    • TABLE 355 GC RIEBER: COMPANY OVERVIEW
    • TABLE 356 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 357 GC RIEBER: PRODUCT LAUNCHES
    • TABLE 358 GC REIBER: DEALS
    • TABLE 359 GC RIEBER: EXPANSIONS
    • 12.1.12 COOKE AQUACULTURE INC.
    • TABLE 360 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
    • TABLE 361 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 362 COOKE AQUACULTURE INC.: DEALS
    • 12.1.13 ALGISYS BIOSCIENCES, INC.
    • TABLE 363 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
    • TABLE 364 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 365 ALGISYS BIOSCIENCES, INC.: OTHERS
    • 12.1.14 GOLDEN OMEGA
    • TABLE 366 GOLDEN OMEGA: COMPANY OVERVIEW
    • TABLE 367 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 368 GOLDEN OMEGA: DEALS
    • 12.1.15 POLARIS
    • TABLE 369 POLARIS: COMPANY OVERVIEW
    • TABLE 370 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 371 POLARIS: PRODUCT LAUNCHES
    • TABLE 372 POLARIS: OTHERS
  • 12.2 OTHER PLAYERS
    • 12.2.1 BTSA
    • TABLE 373 BTSA: COMPANY OVERVIEW
    • TABLE 374 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.2.2 FARBEST BRANDS
    • TABLE 375 FARBEST BRANDS: COMPANY OVERVIEW
    • TABLE 376 FARBEST BRANDS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.2.3 KINOMEGA BIOPHARM INC.
    • TABLE 377 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
    • TABLE 378 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.2.4 PHARMA MARINE AS
    • TABLE 379 PHARMA MARINE AS: COMPANY OVERVIEW
    • TABLE 380 PHARMA MARINE AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.2.5 RIMFROST AS
    • TABLE 381 RIMFROST AS: COMPANY OVERVIEW
    • TABLE 382 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 383 RIMFROST AS: DEALS
    • 12.2.6 ALGARITHM
    • 12.2.7 SOLUTEX
    • 12.2.8 CELLANA INC.
    • 12.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD
    • 12.2.10 ALGAECYTES
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 ADJACENT AND RELATED MARKETS

  • 13.1 INTRODUCTION
    • TABLE 384 ADJACENT MARKETS
  • 13.2 LIMITATIONS
  • 13.3 COLLAGEN MARKET
    • 13.3.1 MARKET DEFINITION
    • 13.3.2 MARKET OVERVIEW
    • TABLE 385 COLLAGEN MARKET, BY FORM, 2019-2022 (USD MILLION)
    • TABLE 386 COLLAGEN MARKET, BY FORM, 2023-2030 (USD MILLION)
  • 13.4 ALGAE PRODUCTS MARKET
    • 13.4.1 MARKET DEFINITION
    • 13.4.2 MARKET OVERVIEW
    • TABLE 387 ALGAE PRODUCTS MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 388 ALGAE PRODUCTS MARKET, BY SOURCE, 2023-2028 (USD MILLION)

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS